[The microagglutination test--a simple and sensitive procedure for serodiagnosis of pertussis infections]

U Heininger1, K Stehr, S Schmitt-Grohe

  • 1Universitätsklinik für Kinder und Jugendliche, Erlangen.

Klinische Padiatrie
|September 1, 1995
PubMed

Insights

The microagglutination assay is a valuable tool for diagnosing whooping cough (Bordetella pertussis) infections, showing high accuracy in patients with confirmed cases. This simple test provides rapid results when advanced methods are unavailable.

Area of Science:

  • Microbiology
  • Immunology
  • Infectious Diseases

Background:

  • Pertussis, caused by Bordetella pertussis, remains a significant public health concern.
  • Accurate and timely diagnosis is crucial for effective patient management and disease control.
  • Existing serological tests for B. pertussis antibodies have varying levels of complexity and accessibility.

Purpose of the Study:

  • To evaluate the diagnostic utility of the microagglutination assay for detecting B. pertussis infections.
  • To compare the advantages and disadvantages of the microagglutination test with other serological methods.

Main Methods:

  • The study involved 30 patients with culture-proven pertussis.
  • Paired acute and convalescent serum specimens were analyzed using the microagglutination assay.
  • Titers were compared between the two serum phases to assess diagnostic sensitivity.

Main Results:

  • A significant fourfold or greater increase in microagglutination titers was observed in 90% (27/30) of patients with confirmed pertussis.
  • The assay requires minimal serum volume (50 microliters) and is standardized, requiring no specialized equipment or expertise.
  • The test is easy to perform, effective across a broad age range, and provides rapid results.

Conclusions:

  • The microagglutination assay is a practical and effective method for diagnosing B. pertussis infections.
  • Its ease of use and speed make it particularly useful in settings where advanced serological tests like ELISA are not immediately available.
  • Potential limitations include the need for paired sera and the inability to differentiate antibody isotypes (IgA, IgG), with recent immunization potentially causing false positives.